Certara (NASDAQ:CERT) Cut to “Hold” at Wall Street Zen

Wall Street Zen downgraded shares of Certara (NASDAQ:CERT) from a buy rating to a hold rating in a research note released on Sunday.

CERT has been the subject of several other research reports. Craig Hallum assumed coverage on shares of Certara in a research report on Monday, September 29th. They set a “buy” rating and a $16.00 price target for the company. Zacks Research raised shares of Certara from a “strong sell” rating to a “hold” rating in a report on Friday, September 5th. KeyCorp increased their price target on Certara from $15.00 to $16.00 and gave the company an “overweight” rating in a research note on Wednesday, October 8th. Barclays reduced their price target on Certara from $16.00 to $14.00 and set an “overweight” rating on the stock in a research report on Friday, November 7th. Finally, BMO Capital Markets began coverage on Certara in a report on Thursday, November 13th. They issued a “market perform” rating and a $9.00 price objective for the company. Six analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, Certara has a consensus rating of “Hold” and a consensus price target of $14.67.

Certara Stock Performance

CERT stock opened at $8.13 on Friday. The company has a 50 day moving average price of $11.45 and a 200 day moving average price of $11.21. Certara has a fifty-two week low of $8.05 and a fifty-two week high of $15.69. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.09 and a quick ratio of 2.09. The stock has a market capitalization of $1.29 billion, a PE ratio of 116.14 and a beta of 1.44.

Certara (NASDAQ:CERT) last released its earnings results on Thursday, November 6th. The company reported $0.14 earnings per share for the quarter, topping analysts’ consensus estimates of $0.11 by $0.03. The company had revenue of $104.62 million during the quarter, compared to the consensus estimate of $104.53 million. Certara had a return on equity of 5.18% and a net margin of 2.62%.During the same quarter in the previous year, the company posted $0.13 earnings per share. Certara has set its FY 2025 guidance at 0.450-0.470 EPS. Analysts forecast that Certara will post 0.28 EPS for the current year.

Insider Buying and Selling

In other Certara news, insider Leif E. Pedersen sold 51,224 shares of Certara stock in a transaction dated Tuesday, September 9th. The stock was sold at an average price of $10.92, for a total transaction of $559,366.08. Following the transaction, the insider directly owned 73,979 shares in the company, valued at approximately $807,850.68. The trade was a 40.91% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 2.33% of the company’s stock.

Hedge Funds Weigh In On Certara

Institutional investors have recently modified their holdings of the business. Private Advisor Group LLC grew its position in shares of Certara by 4.0% in the 1st quarter. Private Advisor Group LLC now owns 24,517 shares of the company’s stock valued at $243,000 after purchasing an additional 949 shares during the period. Associated Banc Corp lifted its stake in Certara by 9.7% in the third quarter. Associated Banc Corp now owns 11,920 shares of the company’s stock valued at $146,000 after buying an additional 1,051 shares in the last quarter. Police & Firemen s Retirement System of New Jersey boosted its holdings in shares of Certara by 2.5% in the second quarter. Police & Firemen s Retirement System of New Jersey now owns 45,745 shares of the company’s stock valued at $535,000 after buying an additional 1,136 shares during the period. Versant Capital Management Inc increased its position in shares of Certara by 66.7% during the third quarter. Versant Capital Management Inc now owns 2,881 shares of the company’s stock worth $35,000 after acquiring an additional 1,153 shares in the last quarter. Finally, Osaic Holdings Inc. increased its position in shares of Certara by 50.7% during the second quarter. Osaic Holdings Inc. now owns 3,491 shares of the company’s stock worth $41,000 after acquiring an additional 1,175 shares in the last quarter. Institutional investors own 73.96% of the company’s stock.

About Certara

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.